The present invention provides a compound represented by the formula (I): wherein each symbol is as defined in the description, or a salt thereof. The compound or a salt thereof or a prodrug thereof has a GPR40 receptor function modulating action and is useful as an insulin secretagogue or an agent for the prophylaxis or treatment of diabetes and the like.
申请公布号
WO2008001931(A3)
申请公布日期
2009.09.11
申请号
WO2007JP63208
申请日期
2007.06.26
申请人
TAKEDA PHARMACEUTICAL COMPANY LIMITED;YASUMA, TSUNEO;NEGORO, NOBUYUKI;YAMASHITA, MASAYUKI;ITOU, MASAHIRO
